Stereotactic body radiation therapy for prostate cancer-Reference-Cited by-同舟云学术

Stereotactic body radiation therapy for prostate cancer

Published:2011-09 Issue:9 Volume:7 Page:1077-1086
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Ishiyama Hiromichi¹²,Teh Bin S,Lo Simon S³,Mathews Thomas¹,Blanco Angel I¹,Amato Robert J⁴,Ellis Rodney J³,Mayr Nina A⁵,Paulino Arnold C¹,Xu Bo¹,Butler E Brian¹

Affiliation:

1. Department of Radiation Oncology, The Methodist Hospital & Research Institute, Houston, TX, USA; The Methodist Hospital Cancer Center, 6565 Fannin, Ste#DB1–077, Houston, Texas 77030, USA

2. Department of Radiology & Radiation Oncology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

3. Department of Radiation Oncology, Case Western Reserve University, UH Seidman Cancer Center, Cleveland, OH 44106, USA

4. Division of Oncology, University of Texas Health Science Center, Houston, TX 77030, USA

5. Department of Radiation Oncology, Arthur G James Cancer Hospital, Columbus, OH 43210, USA

Abstract

Stereotactic body radiation therapy (SBRT) is a promising treatment option for prostate cancer. Hypofractionation regimens, such as SBRT, may be more advantageous compared with conventional regimens because low α:β ratio of prostate cancer has high sensitivity to dose per fraction. In addition, a smaller and tighter margin with SBRT is expected to provide a low toxicity rate without reducing tumor control. The purpose of this article is to examine radiobiological, technical and clinical aspects of SBRT for prostate cancer.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon.11.86

Reference54 articles.

1. American Society for Therapeutic Radiology and Oncology* and American College of Radiology Practice Guideline for the Performance of Stereotactic Body Radiation Therapy

2. Stereotactic ablative radiotherapy: what's in a name?

3. Cancer Statistics, 2010

4. Efficacy of High Dose Per Fraction Radiation for Implanted Human Prostate Cancer in a Nude Mouse Model

5. TehBS, Gao Y, Wang Xet al.In vitroandin vivoefficacy of ablative hypfractionation radiation/stereotactic body radiation therapy (SBRT) for human prostate cancer.Proc. Radiological Soc. North America Annual Meeting. Abstract SSA22–01, (2008).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancer;Journal of Applied Clinical Medical Physics;2018-02-15

2. Stereotactic body radiation therapy for prostate cancer—a review;Chinese Clinical Oncology;2017-09

3. Emerging applications of stereotactic body radiotherapy;Future Oncology;2014-05

4. Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part II: nonspinal tumors;Future Oncology;2013-09

5. Serious Complications Associated with Stereotactic Ablative Radiotherapy and Strategies to Mitigate the Risk;Clinical Oncology;2013-06